3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ketosis
1
Insulin Resistance
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Radiotherapy
4
Blood Specimen Collection
3
Ultrasonography
2
Temozolomide
2
Radiosurgery
2
Pemetrexed
2
Exercise
2
pembrolizumab
1
lithium sulfate
1
ipatasertib
1
dactolisib
1
aumolertinib
1
aflutinib
1
Zinc
1
Surgery, Computer-Assisted
1
Standard of Care
1
Quality of Life
1
Pliability
1
Photic Stimulation
1
Observation
1
Neuropsychological Tests
1
Moxibustion
1
Metformin
1
Mental Status and Dementia Tests
1
Magnetic Resonance Imaging
1
Lomustine
1
Lithium
1
Hypoglycemic Agents
1
Ga(III)-DOTATOC
1
Duloxetine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Hypoglycemic Agents
×
CNS
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled